MBC Group (TADAWUL:4072)
31.30
+0.02 (0.06%)
Jul 31, 2025, 3:18 PM AST
Intercept Pharmaceuticals Revenue
MBC Group had revenue of 2.04B SAR in the quarter ending March 31, 2025, with 65.54% growth. This brings the company's revenue in the last twelve months to 4.99B, up 75.36% year-over-year. In the year 2024, MBC Group had annual revenue of 4.18B with 63.51% growth.
Revenue (ttm)
4.99B
Revenue Growth
+75.36%
P/S Ratio
2.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.18B | 1.63B | 63.51% |
Dec 31, 2023 | 2.56B | -929.31M | -26.64% |
Dec 31, 2022 | 3.49B | 643.26M | 22.61% |
Dec 31, 2021 | 2.85B | 527.89M | 22.78% |
Dec 31, 2020 | 2.32B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition